Grace Li

Grace Li serves as a Member of the Board of Directors for California Life Sciences since November 2020 and is a Non-Executive Director and Co-Founder of Verge Genomics, where the focus is on leveraging artificial intelligence and human data for more efficient drug development. Verge Genomics boasts a comprehensive proprietary patient genomics dataset. Prior to these roles, Grace Li was an MD/PhD candidate at the University of California, Los Angeles - School of Law from June 2010 to June 2015, concentrating on integrative genomics for targeting small molecules that aid in peripheral nerve regeneration. Academic credentials include an MD/PhD in Neuroscience from the David Geffen School of Medicine at UCLA and an A.B. in Molecular Biology with high honors from Princeton University.